The burden of non‐cardiac comorbidities and association with clinical outcomes in an acute heart failure trial – insights from ASCEND‐HF
Sign Up to like & getrecommendations! Published in 2020 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.1795
Abstract: Non‐cardiac comorbidities are highly prevalent in patients with heart failure (HF). Our objective was to define the association between non‐cardiac comorbidity burden and clinical outcomes, costs of care, and length of stay within a large… read more here.
Keywords: clinical outcomes; non cardiac; cardiac comorbidities; heart failure ... See more keywords
Cardiac comorbidities in McArdle disease: case report and systematic review
Sign Up to like & getrecommendations! Published in 2024 at "Neurological Sciences"
DOI: 10.1007/s10072-024-07600-x
Abstract: Myophosphorylase deficiency, also known as McArdle disease or Glycogen Storage Disease type V (GSD-V), is an autosomal recessive metabolic myopathy that results in impaired glycogen breakdown in skeletal muscle. Despite being labelled as a “pure… read more here.
Keywords: coronary artery; disease; cardiac comorbidities; artery disease ... See more keywords
Abstract 4146812: Cardiac Comorbidities has worse outcomes in Multiple Myeloma patients; A retrospective Analysis
Sign Up to like & getrecommendations! Published in 2024 at "Circulation"
DOI: 10.1161/circ.150.suppl_1.4146812
Abstract: Background: Multiple myeloma, a type of blood cancer characterized by recurring and remitting episodes, has historically been difficult to manage. While advancements in treatment have led to improved survival rates, they have also introduced new… read more here.
Keywords: multiple myeloma; value; risk; cardiac comorbidities ... See more keywords
Impact of pulmonary and cardiac comorbidities on cytokine release syndrome incidence in chimeric antigen receptor (CAR) t-treated diffuse large B-cell lymphoma (DLBCL) patients: A real-world data analysis
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-7673
Abstract: Background: CAR T-cell therapies using genetically modified autologous T cells targeting CD19 have been approved for third-line therapy of DLBCL, demonstrating promising results with durable remissions. The most notable associated toxicity is cytokine release syndrome… read more here.
Keywords: therapy; cardiac comorbidities; pulmonary cardiac; car ... See more keywords
Impact of Non-cardiac Comorbidities on Long-Term Clinical Outcomes and Health Status After Acute Heart Failure in China
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.883737
Abstract: Background Individual non-cardiac comorbidities are prevalent in HF; however, few studies reported how the aggregate burden of non-cardiac comorbidities affects long-term outcomes, and it is unknown whether this burden is associated with changes in health… read more here.
Keywords: long term; non cardiac; heart; health status ... See more keywords